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This study investigated the mechanisms of hydroquinone toxicity and assessed the relationships between its cytotoxic, 
genotoxic, and cytogenetic effects tested at 8, 140, and 280 µg mL-1 in human peripheral blood lymphocytes exposed for 
24 h. The outcomes of the treatments were evaluated using the apoptosis/necrosis assay, the alkaline comet assay, and 
the cytokinesis-block micronucleus (CBMN) cytome assay. The tested hydroquinone concentrations produced relatively 
weak cytotoxicity in resting lymphocytes, which mostly died via apoptosis. Hydroquinone’s marked genotoxic effects 
were detected using the alkaline comet assay. Significantly decreased values of all comet parameters compared to controls 
indicated specific mechanisms of hydroquinone-DNA interactions. Our results suggest that the two higher hydroquinone 
concentrations possibly led to cross-linking and adduct formation. Increased levels of DNA breakage measured following 
exposure to the lowest concentration suggested mechanisms related to oxidative stress and inhibition of topoisomerase 
II. At 8 µg mL-1, hydroquinone did not significantly affect MN formation. At 140 and 280 µg mL-1, it completely blocked 
lymphocyte division. The two latter concentrations also led to erythrocyte stabilization and prevented their lysis. At least 
two facts contribute to this study’s relevance: (I) this is the first study that quantifies the degree of reduction in total comet 
area measured in lymphocyte DNA after hydroquinone treatment, (II) it is also the first one on a lymphocyte model that 
adopted the “cytome” protocol in an MN assay and found that lymphocytes exposure even to low hydroquinone 
concentration resulted in a significant increase of nuclear bud frequency. Considering the limitations of the lymphocyte 
model, which does not possess intrinsic metabolic activation, in order to unequivocally prove the obtained results further 
studies using other appropriate cell lines are advised.
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Hydroquinone is an aromatic compound used as a 
reducing agent, antioxidant, polymerization inhibitor, 
chemical stabilizer and intermediate, photographic 
developer, and skin lightening agent in cosmetics and hair 
dyes (1). Hydroquinone also occurs in some plants as free 
hydroquinone or as arbutin (hydroquinone β-D-
glucopyranoside) and may therefore be found in many 
consumer products, such as vegetables, fruits, grains, coffee, 
tea, beer, and wine (2). Two medicinal herbs, bearberry 
[Arctostaphylos uva ursi (L.) Spreng] and strawberry tree 
(Arbutus unedo L.) have attracted particular attention due 
to their high arbutin content, which is responsible for their 
antimicrobial, diuretic, and uroantiseptic properties (3-5). 
Following a bioactivation process with enzyme 
β-glucosidase, arbutin is converted to hydroquinone (6). 
After absorption, free hydroquinone is metabolized in the 
liver, forming conjugates. Hydroquinone elimination from 
the human body occurs via urine in the form of hydroquinone 
sulphate and glucuronide (7). The amount of free 
hydroquinone detected in body was less than 2 % of the 
total arbutin/HQ dose administered and it points to extensive 
conjugation and rapid excretion (8). 
Hydroquinone has been identified as cytotoxic in vitro 
(9) and potentially genotoxic in vivo (4). Hydroquinone’s 
genotoxicity has been extensively studied but an 
unambiguous conclusion could not be made. As reviewed 
by DeCaprio (2), despite no indications for direct 
mutagenicity, hydroquinone is considered to be responsible 
for chromosomal aberrations, abnormal mitoses, formation 
of micronuclei, aneuploidy, and sister chromatid exchanges. 
While Whysner et al. (10) reported that hydroquinone forms 
adducts with DNA in vitro, similar adducts do not occur in 
vivo. Hydroquinone oxidation generates p-benzoquinone, 
which is classified as a carcinogen for rodents and a 
leukemogen for humans (11). On the other hand, it has been 
shown that hydroquinone is a very effective inhibitor of 
lipid peroxidation, which also indicates its antioxidative 
and therefore antimutagenic properties (12). Treatment of 
peripheral blood lymphocytes in vitro with subtoxic and 
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toxic concentrations of hydroquinone during 24, 41, and 
48 hours showed no damage on chromosome structure (9).
The mechanisms that drive the biological effects of 
hydroquinone, especially at cellular level, have not yet been 
fully explained. The contradictory results obtained thus far 
using well-established cytogenetic methods call for further 
studies, which motivated us to perform this investigation. 
Its aim was to explore the mechanisms of hydroquinone 
toxicity and assess the relationships between its cytotoxic, 
genotoxic, and cytogenetic effects tested at 8, 140, and 
280 µg mL-1 in human peripheral blood lymphocytes 
exposed for 24 h. This experimental model was chosen 
since lymphocytes are primary cells with a stable genome, 
commonly used for genotoxicity testing in many 
contemporary studies (13-17). The outcomes of treatment 
were evaluated using the apoptosis/necrosis assay, the 
alkaline comet assay, and the cytokinesis-block micronucleus 
(CBMN) cytome assay. All of these methods are well-
established in genetic toxicology and have proven useful 
in studies with different plant extracts or their active 
constituents (18-26). 
Considering that the results of other similar reports 
regarding hydroquinone toxicity were controversial and 
difficult to confirm unambiguously, our intention was to 
re-assess and verify previous observations using a similar 




Hydroquinone (1,4-dihydroxybenzene; CAS Number: 
123-31-9) was purchased from Sigma-Aldrich (Steinheim, 
Germany). If not specified, other chemicals and reagents 
were obtained from the same supplier. 
Blood sampling 
A peripheral blood sample was collected from a healthy 
male non-smoker (aged 41 years) who was not exposed to 
any known genotoxic agents and did not undergo any 
diagnostic or therapeutic irradiations for one year before 
the study. Written informed consent was obtained from the 
blood donor. This experiment was part of a research 
conducted within the preparation of a PhD thesis of one of 
the co-authors, and has been approved by the Faculty of 
Science, University of Zagreb Ethics Committee.
A total of 20 mL of blood was collected by venepuncture 
under sterile conditions into blood collection tubes (BD 
vacutainer, Becton Dickinson, Franklin Lakes, NJ, USA) 
which contained lithium heparin as an anticoagulant. One 
portion of blood was immediately used for the lymphocyte 
isolation, while the other one was used for the CBMN 
cytome assay.
Isolation of lymphocytes
Lymphocyte isolation was performed using 
Histopaque®1077 reagent (Sigma-Aldrich, St. Loius, MO, 
USA) according to the manufacturer’s instructions (27). 
Whole blood was mixed with an equal volume of cell culture 
medium (Gibco® RPMI 1640 (1X) medium, Life 
Technologies, Paisley, UK). Aliquots of diluted blood were 
carefully layered onto Histopaque®1077 and immediately 
centrifuged at 400×g for 30 minutes (Hettich Rotofix 32 
centrifuge, Tuttlingen, Germany). Then the layer containing 
lymphocytes was carefully aspirated and transferred into a 
centrifuge tube filled with the cell culture medium. This 
solution was gently mixed and centrifuged at 250×g for 
10 min. The same procedure was repeated once more. The 
obtained lymphocyte pellet was resuspended with the cell 
culture medium using a Pasteur pipette. Lymphocyte 
viability was checked using trypan blue staining and was 
over 96 %. There were 2.5×105 cells per mL of the 
suspension. The isolated lymphocytes were then used in 
the experiments.
Experimental design
Selection of the tested concentrations
The tested concentrations were selected adhering to the 
available literature (4, 28-36). The lowest tested 
concentration of 8 µg mL-1 was calculated by taking into 
account (I) the maximum allowable daily intake of 
bearberry leaf extract standardized on arbutin (i.e., 800 mg), 
(II) the average human body weight of 70 kg, and (III) the 
fact that 70 % of arbutin is metabolised into hydroquinone 
(4). Under normal conditions, hydroquinone produced from 
arbutin is rapidly detoxified. However, we wanted to assess 
how severe effects could be produced if this entire amount 
remained available and freely entered into cells. Two higher 
concentrations of 140 and 280 µg mL-1 were calculated 
based on former reports regarding the safety of bearberry 
leaf preparations (35, 36) which did not find significant 
cytogenetic effects or increased micronuclei induction in 
vitro, as well as based on previous related studies (32, 33), 
which tested hydroquinone at millimolar concentrations on 
a lymphocyte model using the MN- and comet assay, 
respectively. 
Lymphocyte treatments
Aliquots of the lymphocyte suspension (V = 1 mL per 
each replica) were placed in sterile Falcon® tubes (Fisher 
Scientific, Pittsburgh, PA, USA) and mixed with the tested 
compound at 8, 140 and 280 µg mL-1. Non-treated 
lymphocytes represented negative control. To prepare a 
positive control sample, lymphocyte suspension was mixed 
with 1.25 µg mL-1 of bleomycin (Nippon Kayaku Co. Ltd., 
Tokyo, Japan). All of the samples were incubated for 24 h 
at 37 °C in 5 % CO2 humidified incubator (Heraeus Hera 
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Cell 240 incubator, Langenselbold, Germany). For each 
experimental group, duplicate samples were set up. 
Following treatment, lymphocyte viability was immediately 
checked (using a double staining procedure with acridine 
orange and ethidium bromide), and agarose microgels for 
the alkaline comet assay were prepared. 
For the CBMN cytome assay, whole blood was treated 
for 24 h at 37 °C with selected hydroquinone concentrations 
or bleomycin (1.25 µg mL-1) for positive control, according 
to recommendations for in vitro treatments (37). Afterwards 
the cell cultures were established and grown for the next 
72 h. Then microscopic slides were prepared and subjected 
to light-microscopic analyses to study cytogenetic outcomes 
and lymphocyte proliferation.
Fluorescent viability assay with ethidium bromide and 
acridine orange (EtBr/AO) staining
As proposed by Duke and Cohen (38), lymphocytes 
were stained with a mixture of fluorescent dyes [100 µg mL-1 
EtBr and 100 µg mL-1 AO dissolved in PBS (1:1 v/v)], and 
immediately analysed under an epifluorescence microscope 
(Olympus BX51, Tokyo, Japan; 400× magnification). Three 
independent scorings were performed and a total of 300 
lymphocytes per  sample per  experiment  were 
morphologically evaluated to determine the percentages of 
viable, apoptotic, and necrotic cells. Viable cells fluoresced 
brightly green due to the intercalation of AO in their DNA. 
Dead cells had a dark orange/red stained nucleus due to the 
binding of EtBr in their DNA. In the early phase of 
apoptosis, green stained fragmented nuclei were visible, 
while late apoptosis was characterized by an orange staining 
of the cytoplasm.
Alkaline comet assay
The alkaline comet assay was performed according to 
standard procedure (39), with minor adjustments. To prepare 
agarose microgels, we used fully frosted precleaned 
microscope slides (Surgipath®, Cambridgeshire, UK) 
precoated with 0.6 % normal melting point (NMP) agarose. 
Over this agarose layer we gently pipetted a second layer 
that was composed of 5 µL of the lymphocyte suspension 
mixed with 0.5 % low melting point (LMP) agarose. The 
top layer was comprised of 0.5 % LMP agarose. These 
microgels were subjected to overnight lysis at 4 °C in a 
freshly mixed buffer [2.5 mol L-1 NaCl (Kemika, Zagreb, 
Croatia), 100 mmol L-1 Na2EDTA, 10 mmol L
-1 Tris-HCl, 
1 % Na-laurilsarcosinate, pH=10] with 1 % Triton X-100 
and 10 % dimethyl sulfoxide (Kemika, Zagreb, Croatia). 
Alkaline denaturation lasted for 20 min in a freshly prepared 
buffer (300 mmol L-1 NaOH, 1 mmol L-1 Na2EDTA, 
pH=13.0). After denaturation, the microgels were arranged 
in a horizontal electrophoresis unit filled with the same 
buffer and subjected to 20 min of electrophoresis (at 4 °C, 
25 V, and 300 mA). Using three changes of 0.4 mol L-1 
Tris-HCl buffer (pH=7.5), the microgels were neutralized 
and washed. Before microscopic analysis, they were stained 
for 10 minutes with 100 µL of EtBr, applied at 20 µg mL-1. 
One well-trained scorer performed all of the comet 
measurements on the coded/blinded slides under an 
epifluorescence microscope (Olympus BX51, Tokyo, Japan; 
at 200× magnification), using a computer-based image 
analysis system with Comet Assay IVTM software 
(Perceptive Instruments Ltd., UK). A total of 200 randomly 
selected comets per each tested concentration (or control) 
were measured on replicate slides in two independent 
evaluations. As indicators of DNA damage, tail length 
(presented in micrometres), tail intensity (i.e., DNA% in 
tail), and total area (it represents the overall surface area of 
the comet) were chosen.
Cytokinesis-block micronucleus (CBMN) cytome assay
We applied a standard protocol for the MN assay as 
recommended by Fenech and Morley (40). For each 
experimental group, duplicate cultures were set up by 
adding blood into Gibco® RPMI 1640 (1X) medium (Life 
Technologies, Paisley, UK) supplemented with inactivated 
foetal calf serum (Gibco®, Invitrogen, Paisley, UK), 
phytohemagglutinin (Remel Europe Ltd., Dartford, UK), 
and antibiotics – penicillin and streptomycin solution 
(Sigma-Aldrich, Steinheim, Germany). Cultures were kept 
at 37 °C in sterile flasks (25 cm2), in 5 % CO2 humidified 
incubator (Heraeus Hera Cell 240 incubator, Langenselbold, 
Germany). At the 44th hour, the cytokinesis blocking agent 
cytochalasine B (Sigma-Aldrich, St. Louis, MO, USA) was 
added (6 µg mL-1). After 72 h of in vitro growth, cultures 
were harvested by standard procedures including incubation 
in hypotonic potassium chloride (Kemika, Zagreb, Croatia) 
solution, and several repetitions of fixation and centrifugation 
(Hettich Rotofix 32 centrifuge, Tuttlingen, Germany) to 
obtain lymphocyte suspension. We used an ice-cold fixative 
made up of 1 part acetic acid (Kemika, Zagreb, Croatia) to 
3 parts methanol (Kemika, Zagreb, Croatia). Lymphocyte 
suspension was dropped onto clean slides. Air-dried slides 
were stained with 5 % Giemsa solution (Merck, Darmstadt, 
Germany) for 10 minutes at room temperature. Microscopic 
analysis was carried out under a light microscope (Leitz, 
Wetzlar, Germany) at 1000× magnification (oil immersion).
The identification and scoring of micronuclei (MN), 
nuclear buds (NB), nucleoplasmic bridges (NPB), and 
apoptotic and necrotic cells was performed using criteria 
recommended by Fenech et al. (41). A total of 2000 
binucleated (BN) cells was examined for each treatment 
(1000 BN cells per each replica). The same slides were used 
to study the nuclear division index (NDI), by screening 
1000 cells per sample (500 cells per slide). To calculate the 
NDI, we used the formula proposed by Eastmond and 
Tucker (42), NDI = (M1 + 2M2 + 3M3 + 4M4)/N, where 
M1-M4 denote the number of cells with 1-4 nuclei, 
respectively, and N is the number of cells scored.
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Statistical analysis
The data were analysed using Dell™ Statistica™ 13.2 
software (Dell Inc., Tulsa, OK, USA). For each data set, 
basic descriptive statistical parameters such as mean, 
standard deviation, standard error, median, and minimum 
and maximum values were determined. To test the normality 
of distribution, we used Shapiro-Wilks Normality Test. The 
data obtained with alkaline comet assay were logarithmically 
transformed to normalise the distribution and equalise 
variances. Multiple comparisons between groups were 
performed using analysis of variance (ANOVA) on log-
transformed data with the Scheffe’s post-hoc test. 
Comparisons between values obtained for lymphocyte 
viability, CBMN assay, and lymphocyte proliferation were 
conducted using Pearson’s χ2-test. The level of statistical 
significance was set at p<0.05.
RESULTS
Lymphocyte viability 
The results obtained using dual ethidium bromide/
acridine orange staining showed a concentration-dependent 
cytotoxicity in all of the hydroquinone-treated samples. At 
the two higher concentrations lymphocyte viability was 
significantly lower than in negative control (Table 1). 
However, as the highest tested concentration caused only 
13 % of dead cells, one could emphasize that at the applied 
in vitro settings hydroquinone had low cytotoxic potential. 
Majority of cells died via apoptosis, which dominated over 
necrosis at the two higher hydroquinone concentrations. 
Treatment with the lowest hydroquinone concentration 
caused the same proportion of apoptotic and necrotic cells. 
Primary DNA damage in peripheral blood lymphocytes 
estimated by the alkaline comet assay
Results regarding primary DNA damage levels in 
peripheral blood lymphocytes measured by the alkaline 
comet assay, and detailed explanations of their statistical 
significance are shown in Table 2. Control lymphocytes had 
low levels of spontaneous primary DNA damage. Twenty-
four-hour treatment with all of the three hydroquinone 
concentrations caused statistically significant deviations in 
almost all of the comet parameters evaluated. As we 
expected, the highest values for all of the comet parameters 
were measured in the positive control sample, which is in 
agreement with the mechanism of hydrogen peroxide action 
to DNA. 
The most prominent change observed after 24-hour 
treatment was a significantly decreased comet total area in 
all of the samples treated with hydroquinone compared to 
negative control. It is worth to mention that the comets 
measured in the sample treated with 8 µg mL-1 of 
hydroquinone had more than a 2-fold lower mean total area 
compared to those measured in the negative control. 
Treatment with 140 µg mL-1 lowered this value by almost 
3.7-fold, while comets measured in the sample treated with 
280 µg mL-1 of hydroquinone had a 4.3-fold lower mean 
total area compared to those measured in the negative 
control. To further document this observation, we calculated 
the average reduction of the total comet area after 
hydroquinone treatments with respect to the control cells 
and these results are shown in Figure 1.
The appearances of lymphocyte nucleoids treated with 
hydroquinone observed under fluorescence microscope after 
staining with ethidium bromide are displayed in Figure 2. 
It should be noted that DNA in the hydroquinone-treated 
samples was more condensed than the DNA in the negative 
control. 
Cytokinesis-block micronucleus cytome assay 
At two higher concentrations tested, hydroquinone 
impaired the in vitro growth of short-term lymphocyte 
cultures, which made it impossible to accomplish the testing 
and obtain valuable slides for the microscopic analysis in 
the CBMN cytome assay. 
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Table 1 Results of the quantitative fluorescent assay for simultaneous identification of apoptotic and necrotic cells in peripheral blood 
lymphocytes treated with hydroquinone in vitro for 24 h and in the negative and positive control samples
Experimental group Viable cells (%) Apoptosis (%) Necrosis (%)
Hydroquinone 8.0 µg mL-1 93.3±1.5 3.3±1.5 3.3±0.6
Hydroquinone 140 µg mL-1 90.3±2.1nc 6.3±1.5 3.3±0.6
Hydroquinone 280 µg mL-1 87.0±2.6nc,h1 8.3±1.5nc,h1 4.7±1.5
Negative control 95.0±0.0 3.0±1.0 2.0±1.0
Positive control 66.0±7.0* 16.7±3.2* 17.3±3.8*
Mean values ± SD of three independent evaluations are shown (3×100 cells per sample per each experimental point were analysed 
under epifluorescence microscope, magnification 400×); Positive control – lymphocytes treated for 24 h in vitro with bleomycin at 
1.25 µg mL-1; Statistical significance of data was evaluated using the χ2 test. The level of statistical significance was set at P<0.05. 
The abbreviations next to the means indicate from which groups the relevant group differs with statistical significance: * – vs. all other 
samples; nc – vs. negative control; h1 – vs. sample treated with 8.0 µg mL-1 hydroquinone
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As shown in Figure 3, despite repeated centrifugation 
and rinsing of the cell pellets, it was not possible to obtain 
lymphocyte suspensions. Microscopic analysis of the 
obtained cell suspensions showed the presence of a large 
number of erythrocytes that were not lysed during the 
sample processing, and almost no lymphocytes. Such a 
result suggests a specific mechanism of hydroquinone action 
on erythrocyte membranes, which will be discussed later 
on.
Results of the CBMN cytome assay suggest a low 
potential of hydroquinone to induce micronuclei at 
8 µg mL-1 (Table 3). However, at the same concentration 
hydroquinone showed significant potential towards the 
formation of nuclear buds (NBs). One of the most typical 
examples of NB appearance visible under the light 
microscope is shown in Figure 4a. There were no 
statistically significant increases in the number of apoptotic 
and necrotic cells with respect to negative control. As 
anticipated, positive control (bleomycin) had the highest 
value for all parameters of the CBMN cytome assay, which 
confirms the sensitivity and specificity of the method used 
(Table 3).
Lymphocyte proliferation analysis
Results regarding lymphocyte proliferation in cell 
cultures treated in vitro with 8.0 µg mL-1 of hydroquinone 
and in the corresponding negative and positive controls are 
reported in Table 4. At the concentration tested, hydroquinone 
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Figure 1 Average reduction of the total comet area observed after 24 h in vitro treatment of peripheral blood lymphocytes with 
hydroquinone applied at three concentrations (percentage of reduction was calculated with respect to the mean total comet area 
measured in the negative control cells)
Table 2 Primary DNA damage in peripheral blood lymphocytes treated for 24 h with hydroquinone applied at three concentrations 
as determined by alkaline comet assay. Negative and positive controls were studied in parallel. Data are reported as mean±SE (first 
row), median (second row), and range (third row)
Experimental group Tail length (µm) Tail intensity (DNA%) Total area


















































Positive control: hydrogen peroxide (H2O2) applied at 100 µmol L-1 on cells embedded into an agarose microgel for 10 minutes on ice; 
For each sample, duplicate slides were prepared and two hundred independent comet measurements per sample per experimental point 
were performed; Statistical significance of data was evaluated using descriptive statistics, ANOVA with post-hoc Scheffé’s test; The 
level of statistical significance was set at P<0.05. The abbreviations above the whiskers indicate which groups differ with statistical 
significance from negative control (nc), or all other groups (*)
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impaired lymphocyte proliferation and significantly lowered 
the nuclear division index (NDI) value compared to negative 
control. The most prominent was a delay of the lymphocyte 
cell cycle in M2, which resulted in a significantly lower 
proportion of M3 cells, as well as a complete absence of 
M4 cells.
DISCUSSION
Although hydroquinone toxicity has been studied in 
various experimental models thus far, which distinguishes 
ours from other previously conducted studies with human 
lymphocytes is its comprehensive design, which coupled 
cell viability assessment with the alkaline comet assay and 
CBMN cytome assay to establish the relationship between 
the cytotoxic, genotoxic, and cytogenetic effects of the 
tested compound. Here we will briefly list the added value 
of our findings. (I) This study is the first to quantify the 
degree of reduction in the total comet area measured in 
lymphocyte DNA after hydroquinone treatment, a parameter 
which the foregoing comet assay studies did not take into 
account when explaining the mechanisms behind the 
infliction of primary DNA damage caused by this 
compound. Based on our observations, the evaluation of 
this particular comet parameter (which points both to the 
changes in the overall surface area of the comet and to the 
impairments in the denaturation step) can be suggested in 
those cases where chemicals with hydroquinone-related 
mechanisms of action at DNA level are studied using the 
conventional alkaline comet assay procedure. (II) None of 
the studies conducted so far with the lymphocyte MN assay 
adopted a “cytome” protocol, to simultaneously evaluate 
the incidence of other cytogenetic changes, such as nuclear 
buds and nucleoplasmic bridges, apart from micronuclei. 
The present study was the first one which reports the results 
of a CBMN cytome assay and found that exposure of 
lymphocytes to even low hydroquinone concentration 
results in a significant increase of nuclear bud frequency. 
Aside from what this study added to the existing knowledge 
on the subject, it also confirmed observations by other 
authors regarding MN induction, disturbed lymphocyte cell 
cycle, toxic effects of hydroquinone, and the mechanisms 
behind its genotoxicity at cell level. The practical 
significance of each result will be discussed below in more 
detail.
When all of the obtained results are taken into account, 
we can say that two of hydroquinone’s effects raised the 
most concern: (I) a significant amount of specific primary 
DNA damage as suggested by the values of alkaline comet 
assay parameters at all of the tested concentrations, and (II) 
a significant impairment of lymphocyte growth in vitro, 
especially at the two higher concentrations. We believe 
these findings are particularly important from the 
toxicological point of view because of the fact that human 
exposure to hydroquinone in some cases can be relatively 
high. Besides occupational exposure, which is limited to 
specific work settings (e.g., production of hydroquinone, 
photographic developers, rubber, and other products that 
contain hydroquinone), there are many sources of 
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Figure 2 Photomicrographs of lymphocyte nucleoids observed after the alkaline comet assay procedure [(a) at hydroquinone 
concentration of 280 µg mL-1; (b) at hydroquinone concentration of 140 µg mL-1; (c) at hydroquinone concentration of 8 µg mL-1; (d) 
negative control. Agarose microgels were stained with ethidium bromide (20 µg mL-1) and analysed under epifluorescence microscope 
(Olympus BX51, Japan), under magnification 200×. Photomicrographs acquired by image analysis system Comet Assay IVTM (Perceptive 
Instruments Ltd., Suffolk, UK)]
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hydroquinone in otherwise “unexposed” people, which 
include smoking, consumption of different foods and 
beverages, use of various herbal preparations and over-the-
counter medicines (for instance paracetamol or 
acetaminophen), as well as the catabolism of proteins 
(especially the amino acid tyrosine) and other substrates by 
microorganisms in the digestive system (2, 8, 43). An 
example of a food item very rich in free hydroquinone is 
pear, with 0.02-0.05 µg g-1 (8). A threat also arises not only 
from excessive intake of free hydroquinone, but also from 
excessive consumption of various items containing its 
glycoside arbutin. Some herbal preparations like bearberry 
and strawberry tree leaf extracts also contain significant 
amounts of arbutin (4, 44). Furthermore, an additional route 
of exposure to arbutin is the dermal one, via application of 
cosmetics preparations, especially creams used for skin 
whitening (45-47). The use of arbutin preparations has 
steadily increased after hydroquinone administration for 
the same purposes was banned by 24th Directive 2000/6/
EC of the European Parliament (48). 
Acute exposure is not associated with significant human 
health risk, considering that hydroquinone undergoes rapid 
metabolism to glucuronide and sulphate ester conjugates 
(2) and has no potential for accumulation in an organism. 
The amount of free hydroquinone in tissues and organs is 
less than 2 % of the total arbutin/hydroquinone dose 
administered (8). However, repeated exposure is a matter 
of concern and this is why the use of herbal preparations 
like bearberry leaf extract should be limited to short periods 
of time (4). 
Most studies with hydroquinone conducted so far, 
including ours, tested the effects of quite high hydroquinone 
concentrations, considering that the maximum exposure 
level to free hydroquinone after ingestion of a therapeutic 
daily dose of bearberry leaf preparation (containing 420 mg 
of arbutin) is estimated to be 11 µg kg-1 b.w. day-1 (8). 
Roughly, if we convert kg to L, this dose corresponds to a 
concentration of 0.011 µg mL-1. 
Interestingly, by testing much higher hydroquinone 
concentrations, we observed a relatively weak cytotoxicity 
in lymphocytes. This was not a surprise, considering that 
lymphocytes are “stuck” in the G0 phase of the cell cycle, 
characterized by the slowing down of many intracellular 
processes (49, 50). The majority of dead cells we detected 
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Table 3 Results of the cytokinesis-block micronucleus cytome assay in lymphocytes treated for 24 h with 8.0 µg mL-1 of hydroquinone, 






Distribution of BN cells according to number of micronuclei (MN)
0 1990 1991 1969
1 9 10 23
2 0 0 5
3 0 0 2
4 0 0 1
BNMN cells (‰ ± SD) 4.5±0.7 5.0±0.0 15.5±2.1*
No. of MN (Mean ± SD) 4.5±0.7 5.0±0.0 21.5±3.5
Distribution of BN cells according to number of NBs
0 1995 1985 1990
1 5 15 10
BNNB cells (‰ ± SD) 2.5±0.7 7.5±0.7
nc 5.0±0.0
No. of NB (Mean ± SD) 2.5±0.7 7.5±0.7 5.0±0.0
Distribution of BN cells according to number of NPBs
0 2000 2000 1997
1 0 0 3
BNNPB cells (‰ ± SD) 0 0 0
No. of NPB (Mean ± SD) 0 0 1.5±0.7
Apoptotic cells (‰ ± SD) 1.0±0.0 2.5±0.7 2.5±0.7
Necrotic cells (‰ ± SD) 0 2.0±1.4 4.0±0.0
BN – binucleated cells; BNMN cells – binucleated cells with micronuclei BNNB cells – binucleated cells with nuclear buds; BNNPB cells 
– binucleated cells with nucleoplasmic bridges; Positive control – lymphocytes treated for 24 h in vitro with bleomycin at 1.25 µg mL-1; 
Microscopic evaluation was performed using a light microscope at 1000× magnification (oil immersion); To establish the MN frequencies, 
2×1000 cells were scored. Data are expressed as mean±SD of two independent evaluations; Statistical significance of the results was 
evaluated using χ2 test. The level of statistical significance was set at P<0.05. For each exposure time intergroup comparisons were 
also done. The abbreviations next to the means indicate from which groups the relevant group differs with statistical significance: * 
– vs. all samples; nc – vs. negative control
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using EtBr/AO staining died via apoptosis. We assume that 
cells which possibly contained highly damaged DNA 
following treatment initiated mechanisms of controlled 
self-killing. However, due to methodological constrains, 
we were not able to deduce which exact mechanisms were 
responsible for hydroquinone-induced apoptosis in our 
experiment since the double fluorescence staining assay 
used in the present study permits only the morphological 
discrimination of dead cells. Therefore, we cannot propose 
the precise mechanisms behind apoptosis, and if the same 
experiment is repeated or expanded in the future, this has 
to be explained using more sophisticated methods for 
apoptosis detection/characterization. However, the 
mechanisms underlying hydroquinone cytotoxicity have 
been explored in several studies on other model systems. 
Hiraku and Kawanishi (51) observed that apoptosis in 
hydroquinone- and benzoquinone-treated HL-60 cells was 
potentiated by internucleosomal DNA fragmentation caused 
mostly by oxidative DNA damage. Inayat-Hussain et al. 
(52) found that hydroquinone caused apoptosis by different 
mechanisms of HL-60 promyelocytic leukaemia cells (via 
caspase-independent pathways) and in myeloperoxidase-
deficient Jurkat T-lymphoblastic leukaemia cells (via 
caspase activation). Terasaka et al. (53) found that treatment 
of HL-60 cells with hydroquinone caused the release of 
cytochrome c and activation of procaspase-3 and -9, 
suggesting that hydroquinone activates the intrinsic 
pathway of apoptosis. Yang et al. (54) found that 
hydroquinone strongly induces apoptosis in neutrophils and 
eosinophils through the caspase 9/3-dependent pathway 
and the increased production of reactive oxygen species. 
Lee at al. (55) reported that the same caspase 9/3 pathway 
was responsible for hydroquinone-induced human 
lymphocyte apoptosis. 
Despite the relatively low cytotoxicity in resting 
lymphocytes, this study found marked genotoxic effects of 
hydroquinone. To estimate the levels of primary DNA 
damage in hydroquinone-treated lymphocytes, we used an 
alkaline version of the comet assay, which detects the widest 
range of lesions (56-58). First literature reports regarding 
hydroquinone effects detected by the comet assay in 
peripheral blood lymphocytes treated in vitro originated 
from Andreoli et al. (59) who found that hydroquinone, 
along with two other benzene metabolites – benzoquinone 
and benzenetriol – exerted a significant genotoxic effect on 
resting lymphocytes, with the lowest effective concentrations 
below 1 µg mL-1. 
Our genotoxicity assessment in lymphocyte model was 
focused on three comet parameters: tail length, tail intensity, 
and total area, all of which were simultaneously measured 
by the Comet Assay IVTM software. Tail length and tail 
intensity are the two most frequently used comet parameters, 
often studied concomitantly. Nevertheless, tail intensity, 
which points to the number of DNA breaks, is considered 
the most suitable indicator of DNA damage (56, 57), as in 
contrast to tail length, it continues to increase beyond a 
critical amount of damage. The reason why we selected 
total area as a parameter of interest was that, following 
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Figure 3 Preparation of lymphocyte samples for CBMN Cytome 
assay [At the bottom of the left tube a cell pellet, obtained by 
repeated fixation (with ice-cold fixative made up of 1 part acetic 
acid to 3 parts methanol) and centrifugation of negative control 
lymphocyte sample is shown (white arrow). The right tube shows 
the lymphocyte sample exposed for 24 h to 140 µg mL-1 of 
hydroquinone which was handled by the same procedure, however, 
it was not possible to lyse and remove erythrocytes from the 
cellular sediment (black arrow)]
Table 4 Effect of hydroquinone on cell proliferation kinetics and nuclear division index (NDI) in lymphocytes treated for 24 h, as well 
as in the negative and positive control samples 
Experimental group
Distribution of cells according to number of nuclei
NDI 
M1 M2 M3 M4
Hydroquinone 8.0 µg mL-1 159 834 7 0 1.848nc
Negative control 148 804 30 18 1.918 
Positive control 326 623 21 30 1.755*
Positive control – lymphocytes treated for 24 h in vitro with bleomycin at 1.25 µg mL-1; NDI – nuclear division index, calculated by 
the following formula: NDI = (M1 + 2M2 + 3M3 + 4M4)/N, where M1-M4 represent the number of cells with 1-4 nuclei, respectively, 
and N is the number of cells scored; Microscopic evaluation was performed using a light microscope at 1000× magnification (oil 
immersion); NDI was determined by examining 2×1000 cells per sample; Statistical significance of the results was evaluated using χ2 
test. The level of statistical significance was set at P<0.05. The abbreviations next to the means indicate from which groups the relevant 
group differs with statistical significance: * – vs. all other samples; nc – vs. negative control
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extensive analysis of the obtained results, this parameter 
pointed to interesting discoveries regarding hydroquinone 
genotoxicity. This parameter has not frequently been 
involved in the evaluation of comet assay results, but the 
results reported in certain previous studies (59-63) confirm 
its value. 
We found that 24-h treatment with all three hydroquinone 
concentrations caused statistically significant deviations of 
almost all of the evaluated comet parameters. Their values 
were markedly decreased compared to control, which 
indicated specific mechanisms of hydroquinone-DNA 
interactions. Significantly lower DNA migration compared 
to control, and especially reduced total area of the comets 
we observed in hydroquinone-treated cells might indicate 
formation of cross-links, which in turn impaired denaturation 
of DNA. This assumption is highly possible, as formation 
of DNA-protein cross-links was previously documented in 
a study by Amin and Witz (64) in HL-60 cells exposed to 
25-100 µmol L-1 of hydroquinone for 4 h. Similarly, Luo et 
al. (65) in their comet assay study in HepG2 cells observed 
the maximum of DNA migration at 25 µmol L-1 of 
hydroquinone, while exposure to 50 µmol L-1 caused a 
reduction in DNA migration, which they related to the 
formation of DNA-protein cross-links. Considering what 
is known about the mechanisms of action for hydroquinone, 
and our own findings, we propose that exposure to 
hydroquinone at the two higher doses led to the formation 
of intra- and inter-strand DNA-DNA and DNA-protein 
cross-links, possibly also to formation of adducts in 
lymphocyte DNA, which prevented normal DNA 
denaturation during the alkaline denaturation step, and 
hindered DNA migration during electrophoresis. 
As another important mechanism of hydroquinone 
action at DNA level, the available literature suggests the 
inhibition of topoisomerase II enzyme (66-68) and induction 
of oxidative stress (33, 65), resulting in a significant amount 
of DNA breaks. According to Andreoli et al. (33), 
hydroquinone produces significantly more primary DNA 
damage in isolated human lymphocytes than in the whole 
blood leukocyte population. This was primarily due to the 
influence of the enzymes catalase and glutathione 
peroxidase from erythrocytes (present in whole blood 
samples) on reactive hydroquinone metabolites and free 
radicals. Furthermore, under the influence of the enzyme 
myeloperoxidase [which is normally present in white blood 
cells (69)], hydroquinone is also converted into the more 
toxic reactive metabolite benzoquinone. It is known as a 
potent inducer of DNA adducts (70), aneugen, and potent 
inducer of micronuclei (29, 71). As mentioned before, our 
results suggest that the two higher hydroquinone 
concentrations possibly led to cross-linking and adduct 
formation. However, it is high likely that following 
exposure to the lowest tested concentration, the inhibition 
of topoisomerase II possibly played a more important role 
than cross-linking. This was sustained by the significantly 
higher values of all comet assay parameters measured in 
the sample treated with 8 µg mL-1 compared to the other 
two hydroquinone-treated samples. Also, findings by Frantz 
et al. (66) suggest that 1,4-benzoquinone inhibited 
topoisomerase II in in vitro conditions at concentrations of 
≥10 µmol L-1. The lowest tested hydroquinone concentration 
in our study corresponded to 72.6 µmol L-1, which speaks 
in favour of the same effects. 
Considering that the alkaline comet assay cannot 
provide information about lymphocyte proliferation status, 
we extended our research to the CBMN cytome assay, one 
of the most comprehensive methods which enables the 
simultaneous study of chromosome damage, mitotic spindle 
apparatus damage, cell cycle kinetics, and cytotoxicity in 
treated cell cultures (37, 72, 73). 
Hydroquinone potency towards MN induction in human 
peripheral blood lymphocytes in vitro was tested in several 
studies so far (28-34, 74). The reported results are rather 
controversial, mainly due to different exposure conditions, 
duration of lymphocyte cultivation, and time of hydroquinone 
administration. In some studies, isolated lymphocytes were 
treated (29, 32, 34, 74), while other used whole blood 
cultures (28, 30, 31). MN induction was observed after 
exposure to a wide range of hydroquinone concentrations, 
mainly corresponding to 1-300 µmol L-1. One of the most 
comprehensive study designs was applied by Lippoli 
Doepker et al. (34), who, in an attempt to overcome the 
limitations of previous studies evaluated three different 
variations of the MN assay. They did not observe a 
significant increase in MN frequency in cultures of isolated 
lymphocytes treated with 12.5-200 µmol L-1 of hydroquinone. 
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Figure 4 Photomicrographs of binucleated lymphocytes observed after the 24 h exposure to 8.0 µg mL-1of hydroquinone [(a) binucleated 
lymphocyte with nuclear bud; (b) apoptotic lymphocyte; (c) necrotic lymphocyte. Stained with Giemsa dye. Photographed under light 
microscope at magnification 1000×]
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As mentioned in the Results section, the present study 
was only able to analyse preparations obtained from a 
sample exposed to the lowest tested hydroquinone 
concentration, which corresponded to 72.6 µmol L-1. In that 
sample, there was no significant deviation in MN number 
compared to negative control. These findings are comparable 
to previous reports by Migliore and Nieri (28) and Van 
Hummelen and Kirsch-Volders (30), who at similar 
concentrations also did not record a significant increase in 
MN in the donors of blood used for testing. 
We have to stress that none of the aforementioned 
studies evaluated the incidence of other types of cytogenetic 
damage covered by the “cytome” assay, as we have done. 
Therefore, our study added original and novel information 
regarding hydroquinone cyto/genotoxicity at cellular level. 
Particularly important was the finding regarding a 
significantly increased incidence of nuclear buds. Nuclear 
budding happens during the S-phase of a cell cycle, and it 
is likely that DNA repair processes resulted in the formation 
of excessive amplified DNA, which concentrated in the 
peripheral part of the nucleus and budded out (72). As 
mentioned before, we also found increased level of primary 
DNA damage, which was obviously repaired during 
lymphocyte growth in vitro. However, since our CBMN 
assay focused only at one concentration, the observed 
phenomenon of nuclear budding following hydroquinone 
treatment has to be proven further by testing a much wider 
range of concentrations, not only in lymphocytes, but also 
in other cell types in order to obtain greater insight into the 
mechanism of their formation after exposure to the tested 
compound. 
Among the other endpoints studied, we also evaluated 
how the tested compound influences lymphocyte 
proliferation. Judging from the values of the nuclear 
division index, hydroquinone at 8 µg mL-1 (or 72.6 µmol L-1) 
significantly impaired lymphocyte cell kinetics compared 
to control. Our observations regarding lymphocyte 
proliferation are consistent with previous investigations. 
Lippoli Doepker et al. (34) found a block in lymphocyte 
division at certain hydroquinone concentrations, which was 
demonstrated by a decrease in the percentage of binucleated 
cells and the value of the division index. In their study, MN 
scoring was limited to concentrations of 25, 50 or 
75 µmol L-1 and above, depending on the blood donor. 
Previous studies that used whole blood in MN assay also 
reported mitotic delays and cytotoxicity as limiting factors 
to ultimately accomplish the assay, particularly at high 
hydroquinone concentrations. Migliore and Nieri (28) 
reported cytotoxicity at 200 µmol L-1, while Ferguson et al. 
(31) observed cytotoxicity at >300 µmol L-1 or 400 µmol L-1, 
depending on the blood donor. 
Up to now, millimolar concentrations of hydroquinone, 
comparable to two of our higher concentrations 
(1.27 mmol L-1 and 2.54 mmol L-1) have been tested in an 
MN assay only by Vian et al. (32) on isolated lymphocytes. 
They observed that >1 mmol L-1 and 2 mmol L-1 (depending 
on the blood donor) produced cytotoxicity. This paper 
obtained quite comparable results regarding cytotoxicity. 
To find an appropriate explanation why hydroquinone-
treated cells did not grow in vitro at the two higher 
concentrations examined in our study, we have to call to 
memory the mechanisms of hydroquinone toxicity clarified 
in previous studies. It is highly likely that in the experimental 
conditions of MN assay where whole blood was introduced 
into the culture, hydroquinone metabolites, benzoquinone 
in particular, inhibited phytohemagglutinin-stimulated 
lymphocyte division. A similar effect was observed for 
1,4-benzoquinone by Irons et al. (75) in rat spleen 
lymphocytes. Lippoli Doepker et al. (34) also reported that 
hydroquinone caused more impairment in the growth of 
cultures of isolated lymphocytes used in the MN assay than 
in cultures established using whole blood. They assume 
that when whole blood was used, the presence of additional 
proteins and cell types stabilizes hydroquinone, diminishes 
the formation of oxidative species, and offers additional 
binding sites for its reactive metabolite benzoquinone. As 
a consequence, the levels of oxidative degradation products 
capable of interacting with the mitotic apparatus are 
reduced, which also reflects upon the cell cycle delays. 
Furthermore, we also have to mention that another 
possible reason for the failed testing using the CBMN 
cytome assay with the two higher hydroquinone 
concentrations possibly stood behind its specific effect on 
erythrocytes. This result indicates the possibility that 
hydroquinone specifically disturbed erythrocyte membranes. 
The large amount of erythrocytes we found in cell 
suspensions suggests that hydroquinone (or its metabolites) 
prevented erythrocyte haemolysis, which is an important 
step in the rinsing of lymphocyte pellets during the 
preparation of slides for the micronucleus assay. According 
to Denny (76), this is very likely because benzoquinone did 
not cause haemolysis and instead protected erythrocytes 
from haemolytic stresses. As known, erythrocytes contain 
numerous proteins (77). Having in mind that benzoquinone 
leads to adduct formation in haemoglobin and albumin (78, 
79), it is likely that interaction between benzoquinone and 
proteins prevent haemolysis. Similar effects of quinone and 
hydroquinone on proteins have been noted by other authors 
(80-82). It is possible that such an effect of hydroquinone 
and its metabolites present in short-term lymphocyte 
cultures established from whole blood in some way leads 
to erythrocyte stabilization and their inability to remove 
from the cell pellet formed after centrifugation. However, 
these assumptions have to be further studied.
Conclusions and future perspectives
This study is to a certain extent limited by the fact that 
it was accomplished on an in vitro model, which means that 
the results cannot be directly extrapolated to real in vivo 
conditions. Although the lymphocyte model is common in 
genetic toxicology testing and has been recently used in 
studies employing similar methods as ours (13, 14, 17), the 
fact that human lymphocytes represent a population of 
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resting cells that do not possess intrinsic metabolic 
activation suggests the need for further studies using other 
appropriate cell lines to unequivocally prove the obtained 
results. Lastly, we are aware that testing a much wider range 
of hydroquinone concentrations and using more sophisticated 
methods (e.g., specific modifications of the comet assay 
and more accurate methods for the detection of apoptosis) 
would provide a more accurate explanation of the observed 
effects, but at the moment this was not possible due to 
various technical and financial constraints.
When the results obtained by testing of hydroquinone 
in vitro are considered in their entirety, the genotoxic risk 
of exposure to its lowest concentration, which is far above 
the amount of hydroquinone produced by the metabolism 
following an uptake of the maximum daily allowable 
concentration of arbutin, is also relatively low. On the other 
hand, exposure to the two higher hydroquinone 
concentrations, which produced more detrimental effects 
in vitro, is not likely to be achieved in actual in vivo 
conditions. Taken together, in spite of all of the limitations, 
our findings should provide valuable information regarding 
hydroquinone toxicity and represent a solid base for our 
future investigations.
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Istraživanje citotoksičnih, genotoksičnih i citogenetičkih učinaka hidrokinona na  
ljudskim limfocitima periferne krvi u uvjetima in vitro
Cilj ovog istraživanja bio je proučiti mehanizme toksičnosti hidrokinona i odnose između njegovih citotoksičnih, 
genotoksičnih i citogenetičkih učinaka na ljudskim limfocitima periferne krvi izloženima koncentracijama 8, 140 i 280 
µg mL-1 tijekom 24 sata. Posljedice izlaganja testiranom spoju istražene su primjenom testa za otkrivanje stanica u apoptozi 
i nekrozi, komet-testa u alkalnim uvjetima i tzv. cytome inačice citohalazinom blokiranog mikronukleus-testa. Istražene 
koncentracije hidrokinona izazvale su relativno nisku citotoksičnost u limfocitima, koji većinom ugibaju apoptozom. 
Međutim, pri istim koncentracijama primjenom komet-testa uočene su značajne promjene u razinama primarnih oštećenja 
DNA u odnosu na kontrolu. Statistički značajno snižene vrijednosti svih parametara komet-testa u odnosu na kontrolne 
stanice upućuju na specifične mehanizme međudjelovanja hidrokinona i DNA. Dobiveni rezultati upućuju na mogućnost 
nastanka ukriženih veza u molekuli DNA (engl. cross-linking) i nastanak adukata u DNA nakon izloženosti dvjema višim 
koncentracijama hidrokinona, a povišene vrijednosti lomova u DNA, uočene nakon izlaganja najnižoj ispitanoj 
koncentraciji, upućuju na veći značaj oksidacijskih oštećenja i utjecaj mehanizama povezanih s inhibicijom enzima 
topoizomeraze II. Pri koncentraciji 8 µg mL-1 hidrokinon ne izaziva značajan porast broja mikronukleusa. Koncentracije 
140 i 280 µg mL-1  potpuno koče diobu limfocita, a ujedno izazivaju i stabilizaciju membrana eritrocita, sprječavajući 
njihovu lizu. Dva dobivena rezultata značajan su doprinos postojećim saznanjima o toksičnosti hidrokinona: (I.) Ovo je 
prvo istraživanje u kojem je izmjereno smanjenje ukupne površine kometa limfocitne DNA nakon izlaganja hidrokinonu; 
(II.) Ovo je prvo istraživanje u kojem je primijenjena cytome inačica mikronukleus-testa, kojom smo dokazali da izloženost 
čak i vrlo niskim koncentracijama hidrokinona dovodi do značajno povišene učestalosti nastanka jezgrinih pupova u 
limfocitima. Uzevši u obzir ograničenja limfocita kao modela, ponajprije nedostatak unutarnje metaboličke aktivacije, 
za nedvojbenu potvrdu dobivenih rezultata predlažemo nastavak istraživanja i na drugim prikladnim modelima staničnih 
linija.
KLJUČNE RIJEČI: apoptoza; citohalazinom blokiran mikronukleus cytome test; jezgrini pupovi; primarna oštećenja 
DNA; ukupna površina kometa
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